Brief: Royalty Pharma Reports Second Quarter 2026 Results
BRIEF-Royalty Pharma Reports Second Quarter 2026 Results Aug 5 (Reuters) - Royalty Pharma PLC RPRX.O:
ROYALTY PHARMA REPORTS SECOND QUARTER 2026 RESULTS
Source text: ID:nGNX5fkvP4
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)